Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 24.920% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CCN(CC)C(=O)CSc1nc2ccsc2c(=O)n1CCCC(=O)NCCc1ccc(S(N)(=O)=O)cc1
[b] O=C1c2c(Br)c(Br)c(Br)c(Br)c2C(=O)N1c1ccccn1
Answer: b. O=C1c2c(Br)c(Br)c(Br)c(Br)c2C(=O)N1c1ccccn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1c2c(Br)c(Br)c(Br)c(Br)c2C(=O)N1c1ccccn1
O=C1c2c(Br)c(Br)c(Br)c(Br)c2C(=O)N1c1ccccn1
4,5,6,7-tetrabromo-2-pyridin-2-ylisoindole-1,3-dione